Invention Grant
- Patent Title: Chemically programmable immunity
- Patent Title (中): 化学可编程免疫
-
Application No.: US12336746Application Date: 2008-12-17
-
Publication No.: US08236321B2Publication Date: 2012-08-07
- Inventor: Kary B. Mullis
- Applicant: Kary B. Mullis
- Applicant Address: US CA Corona Del Mar
- Assignee: Altermune Technologies, LLC
- Current Assignee: Altermune Technologies, LLC
- Current Assignee Address: US CA Corona Del Mar
- Agency: Davis Wright Tremaine LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K31/7088 ; A61K31/7125 ; A61K31/713

Abstract:
The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
Public/Granted literature
- US20090142368A1 Chemically Programmable Immunity Public/Granted day:2009-06-04
Information query